Gilead Sciences Inc. Chief Executive Officer Daniel O’Day said the company’s new HIV prevention drug Yeztugo should be able ...

Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...

Saint Giles Hospital is currently treating a 14-year-old patient with HIV linked to drug use, highlighting a worrying trend.

I n July, Meghalaya Health and Family Welfare Minister Mazel Ampareen Lyngdoh announced that the State may follow Goa in ...

High stigma due to HIV was also associated with depression and drug use, making the reduction in stigma vital for improving the care of women with HIV.

Caroline Flynn's four-year-old son suffered a terrifying HIV scare after he was pricked in the foot by a dirty hypodermic needle that had been discarded in a South Boston park.

Opinion: By dismantling proven HIV prevention and overdose reduction programs, the Trump administration is replacing science ...

Patients with HIV who are resistant to all four antiretroviral drug classes face a higher risk for death than those who are ...

New HIV infections in Shelby County jumped 18% during the first three years of the 5-year-old End HIV 901 campaign. Yet the county has also seen increases ...

Analysts lift targets for Gilead as HIV sales surge and Yeztugo launch gains traction, supporting a stronger full-year ...

Gilead Sciences (NASDAQ:GILD) announced its second-quarter 2025 earnings and revised annual outlook after the market closed ...

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human ...